A Phase I, Safety Tolerability and Pharmacokinetics of AZD4831 to Treat Cardiovascular Disease

Trial Identifier:	D6580C00004
Sponsor:	AstraZeneca
Collaborator:	PAREXEL
NCTID::	NCT03136991
Start Date:	May 2017
Primary Completion Date:	November 2017
Study Completion Date:	November 2017
Condition:	Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States of America, CA	Glendale, CA, United States of America, 91206

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.